{
    "Title": "Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults",
    "URL": "https://doi.org/10.1371/journal.pntd.0006340",
    "Published": "June 6, 2018",
    "Subject_Areas": [
        "Rabies",
        "Vaccination and immunization",
        "Vaccines",
        "Antibodies",
        "Rabies virus",
        "Antigens",
        "Vaccine development",
        "Post-exposure prophylaxis"
    ],
    "Authors": {
        "Phirangkul Kerdpanich": [
            "Department of Pediatrics, Division of Infectious Diseases, Phramongkutklao Hospital, Bangkok, Thailand"
        ],
        "Pornthep Chanthavanich": [
            "Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand"
        ],
        "Mari Rose De Los Reyes": [
            "Research Institute for Tropical Medicine, Filinvest Corporate City, Alabang Muntinlupa City, the Philippines"
        ],
        "Jodor Lim": [
            "Asian Hospital and Medical Center, Filinvest Corporate City, Alabang Muntinlupa City, the Philippines"
        ],
        "Delia Yu": [
            "De La Salle Health Sciences Institute-Congressional Road, Dasmarinas City, Cavite, the Philippines"
        ],
        "Ma. Cecilia Ama": [
            "Research Institute for Tropical Medicine, Filinvest Corporate City, Alabang Muntinlupa City, the Philippines"
        ],
        "Zenaida Mojares": [
            "GSK, Siena, Italy"
        ],
        "Daniela Casula": [
            "GSK, Siena, Italy"
        ],
        "Ashwani Kumar Arora": [
            "GSK, Siena, Italy"
        ],
        "Michele Pellegrini": [
            "GSK, Siena, Italy"
        ]
    }
}